Danish biotech replaces 1980s cell-based methods with revolutionary cell-free technology, making gene therapy more accessible. Innovative approach allows for unprecedented quality in hours rather than ...

National Biotechnology Conference, gene therapies, bispecific antibodies and other novel modalities—relative newcomers to ...

Precigen on Tuesday said a green light would make PRGN-2012 the only FDA-approved therapeutic for the treatment of adults with the disorder, which is a lifelong neoplastic disease of the upper and ...